Showing results (31-40 of 171) with videos related to

Sort By:
Pageof 18
International Journal of Pharmaceutics|July 22, 2022
Inhaled therapy for COVID-19: Considerations of drugs, formulations and devicesTushar Saha, Miguel E Quiñones-Mateu, Shyamal C Das
International Journal of Pharmaceutics|April 20, 2016
Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosisBasanth Babu Eedara, Ian G Tucker, Shyamal C Das
International Journal of Pharmaceutics|January 27, 2019
In vitro dissolution testing of respirable size anti-tubercular drug particles using a small volume dissolution apparatusBasanth Babu Eedara, Ian G Tucker, Shyamal C Das
Journal of Bacteriology|June 18, 2014
AraC/XylS family stress response regulators Rob, SoxS, PliA, and OpiA in the fire blight pathogen Erwinia amylovoraDaniel Pletzer, Gabriel Schweizer, Helge Weingart
Journal of Bacteriology|April 13, 2016
Antibiofilm Peptides: Potential as Broad-Spectrum AgentsDaniel Pletzer, Robert E W Hancock
International Journal of Antimicrobial Agents|April 30, 2025
A review of recently discovered mechanisms of cephalosporin resistance in Pseudomonas aeruginosaMadeleine T Hardie Boys, Daniel Pletzer
Drug Development and Industrial Pharmacy|April 17, 2019
The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicinMohammad A M Momin, Ian G Tucker, Shyamal C Das
International Journal of Pharmaceutics|September 5, 2018
High dose dry powder inhalers to overcome the challenges of tuberculosis treatmentMohammad A M Momin, Ian G Tucker, Shyamal C Das
Pageof 18